Related Experiment Video
Updated: May 27, 2026
08:49
Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Bivalent molecular probes for dopamine D2-like receptors
Daniela Huber1, Stefan Löber, Harald Hübner
1Department of Chemistry and Pharmacy, Emil Fischer Center, Friedrich Alexander University, Schuhstrasse 19, D-91052 Erlangen, Germany.
Bioorganic & Medicinal Chemistry
|November 22, 2011
Summary
Bivalent ligands targeting dopamine receptors showed significantly enhanced affinity and selectivity, particularly for the D(3) subtype. These compounds bind to both orthosteric and allosteric sites, improving drug design for neurological disorders.
Area of Science:
- Medicinal Chemistry
- Neuropharmacology
- Molecular Biology
Background:
- Dopamine receptors, particularly D(2)-like subtypes, are crucial targets for treating neurological and psychiatric disorders.
- Developing selective ligands for dopamine receptor subtypes remains a significant challenge in drug discovery.
Purpose of the Study:
- To synthesize and characterize novel bivalent ligands by linking arylamidoalkyl phenylpiperazines with oligoethylene glycol linkers.
- To evaluate the binding affinity and subtype selectivity of these bivalent ligands against dopamine D(2long), D(2short), D(3), and D(4) receptors.
Main Methods:
- Synthesis of bivalent ligands and their monomeric analogues.
- Radioligand binding assays to determine receptor affinity and selectivity.
- Analysis of binding curves to understand ligand-receptor interactions.
Main Results:
- Bivalent ligands demonstrated significant "bivalent effects," particularly for para-substituted benzamide derivatives.
- Compounds 32, 34, and 36 exhibited up to a 70-fold increase in affinity and enhanced subtype selectivity for the D(3) receptor compared to monovalent analogues.
- Hill slopes close to one indicated displacement of one equivalent of radioligand, suggesting occupation of distinct binding sites.
Conclusions:
- Bivalent ligands can achieve superior affinity and selectivity for dopamine receptor subtypes compared to their monovalent counterparts.
- The observed binding mode suggests the pharmacophores occupy an orthosteric and an allosteric site, rather than bridging the receptor.
- These findings offer a promising strategy for designing novel therapeutics targeting dopamine receptors.
